Exact claim · Version 1 · Reviewed 2026-07-23
“Epitalon is proven to treat insomnia.”
A verdict on this wording and scope, not a universal grade for Epitalon.
01 · Verdict
Not established
FDA did not identify clinical insomnia studies of the nominated epitalon substances by the proposed route.
- Evidence basis
- No reliable human outcome evidence
- Scope
- Adults with insomnia assessed using clinical sleep outcomes.
- Category
- Clinical outcomes
02 · Primary record
Check the attached evidence
- Editorial review
- Internal editorial review recorded
- Responsible editor
- Anthony Treviso · Founder and responsible editor
- Clinical-review boundary
- Not independently medically reviewed.